Plausible biomarkers for noninvasive endometriosis diagnosis
Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) are promising biomarkers for noninvasive diagnosis of endometriosis
Key Points Lay Summary
Nanotechnology as a tool for targeted therapy of endometriosis
Can nanoparticle technology be utilized to specifically target proliferating endometriotic cells for future medical therapy?
Key Points Lay Summary
How to Classify Endometriosis for a better and effective evaluation
In the current classification system, the stages of the lesions, in terms of their deep molecular biology and their evolution, cannot compare as similar.
Key Points Lay Summary
Mortality of 49956 midlife women with surgically verified endometriosis
Lower Mortality in midlife women with surgically verified endometriosis.
Key Points Lay Summary
Which Diagnosis Technique is Better?
Transvaginal ultrasound seems to be more accurate in detecting the localization of vaginal and recto-vaginal endometriosis while magnetic resonance imaging is better in localizing bladder endometriosis.
Key Points Lay Summary
Pregnancy with endometriosis
Maternal and neonatal outcomes according to the location of the disease
Key Points Lay Summary
Prescription Opioid Use in Women With Endometriosis
Women with endometriosis are more likely to use opioids, for prolonged periods, and concomitantly with benzodiazepines compared to women without this condition.
Key Points Lay Summary